Metals in the Trial to Assess Chelation Therapy 2

Lead PI: Ana Navas-Acien

Unit Affiliation: Mailman School of Public Health

October 2016 - April 2021
Inactive
North America
Project Type: Research

DESCRIPTION: The main objectives of the Metals in the Trial to Assess Chelation Therapy 2 (TACT2M) are to evaluate whether long-term edetate disodium (EDTA)-based chelation infusions can significantly reduce body lead and cadmium levels and to determine whether this effect explains the reduction in major cardiovascular events caused by EDTA chelation therapy in patients with diabetes. This is a companion study to TACT2, the clinical trial currently funded for a UG3 Planning Year.

SPONSOR:

Mount Sinai Medical Center-Miami

ORIGINATING SPONSOR:

National Center for Complementary and Integrative Health/NIH/DHHS

KEYWORDS

cadmium (cd) edetate disodium (edta) lead (Pb) chelation therapy diabetes health